Latest Mark G. Lebwohl Stories
DUBLIN, March 20, 2015 /PRNewswire/ -- Dignity Sciences (DS) is today presenting a late-breaking news abstract at the annual meeting of the American Association of Dermatology
Beverly Hills’ celebrity cosmetic dermatologist and renowned expert on advanced skin treatments, Dr. Paul W.
AUSTIN, Texas, March 4, 2015 /PRNewswire/ -- XBiotech announced today that results from its Phase II pilot study in patients with moderate to severe plaque psoriasis have been published in JAMA
Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo THOUSAND OAKS, Calif. and LONDON, Nov.
Los Angeles Dermatologic Surgeon Discusses Trends in Cosmetic Surgery at Annual CACS Meeting LOS ANGELES, Oct. 28, 2014 /PRNewswire/ -- Elite dermatologic surgeon Dr.
- Biologics License Application (BLA) for secukinumab, a "first-in-class" IL-17A inhibitor, is currently under FDA review with an anticipated action date in early 2015 EAST
Nearly half a million dollars given to early-career physicians to study psoriatic disease PORTLAND, Ore., July 17, 2014 /PRNewswire-USNewswire/ -- Twelve residents and medical students each
While YouTube might be a popular destination for viral videos and sports highlight reels, it’s also useful for raising awareness of skin cancer and prevention techniques, according to a new report in the Dermatology Online Journal.
- Results of two Phase III psoriasis studies show secukinumab, the first psoriasis IL-17A inhibitor filed with regulatory bodies, met all co-primary and key secondary endpoints
Mount Sinai Dermatologists Identified Many with Sun-damaged Skin over Ten Days NEW YORK, NY (PRWEB) July 03, 2014 Dermatologists from the Mount Sinai
- A hairdresser.